- Home
- FBIO vs EML Comparison
FBIO vs EML Comparison
Compare FBIO & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBIO | EML |
|---|---|---|
| Founded | 2006 | 1858 |
| Country | United States | United States |
| Employees | 101 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.6M | 119.2M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | FBIO | EML |
|---|---|---|
| Price | $2.47 | $20.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 423.6K | 16.5K |
| Earning Date | 03-31-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.17% |
| EPS Growth | N/A | ★ 185.40 |
| EPS | N/A | ★ 1.17 |
| Revenue | N/A | ★ $248,970,345.00 |
| Revenue This Year | $29.71 | $19.05 |
| Revenue Next Year | $49.34 | N/A |
| P/E Ratio | ★ N/A | $17.30 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.33 | $17.61 |
| 52 Week High | $4.53 | $26.76 |
Technical Indicators
Market Signals| Indicator | FBIO | EML |
|---|---|---|
| Relative Strength Index (RSI) | 30.65 | 57.85 |
| Support Level | $2.47 | $18.73 |
| Resistance Level | $2.71 | $21.17 |
| Average True Range (ATR) | 0.17 | 0.60 |
| MACD | -0.04 | -0.05 |
| Stochastic Oscillator | 1.36 | 53.78 |
Price Performance
Historical ComparisonAbout FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.